GostinL.O., Public Health Law: Power, Duty, Restraint (Berkeley: University of California Press, 2000).
2.
Id. at 4.
3.
Id.
4.
Id.
5.
Id. at 4–5.
6.
DragerN.BeagleholeR., “Globalization: Changing the Public Health Landscape,”Bulletin of the World Health Organization, 79 (2001): 803;.
7.
DollarD., “Is Globalization Good for Your Health?,”Bulletin of the World Health Organization, 79 (2001): 827–33;.
8.
CorniaG.A., “Globalization and Health: Results and Options,”Bulletin of the World Health Organization, 79 (2001): 834–41;.
9.
LeeK., Globalisation and Health: An Introduction to Global Health (London: Macmillan/St. Martin's Press, in press);.
10.
LeeK., ed., Globalisation and Health: Case Studies (London: Macmillan/St. Martin's Press, in press);.
11.
LeeK.BuseK.FustukianS., eds., Crossing Boundaries: Health Policy in a Globalising World (Cambridge: Cambridge University Press, in press);.
12.
YachD.BettcherD., “The Globalization of Public Health, I: Threats and Opportunities,”American Journal of Public Health, 88 (1998): 735–37;.
13.
YachD.BettcherD., “The Globalization of Public Health, II: The Convergence of Self-Interest and Altruism,”American Journal of Public Health, 88 (1998): 738–41;.
14.
WaltG., “Globalisation of International Health,”The Lancet, 351 (1998): 434–37;.
15.
FidlerD.P., “The Globalization of Public Health: Emerging Infectious Diseases and International Relations,”Indiana Journal of Global Legal Studies, 5 (1997): 11–51.
16.
ScholteJ.A., “The Globalization of World Politics,” in BaylisJ.SmithS., eds., The Globalization of World Politics (Oxford: Oxford University Press, 1997): 13–47.
17.
SmithS.BaylisJ., “Introduction,” in BaylisJ.SmithS., eds., The Globalization of World Politics (Oxford: Oxford University Press, 1997): 1–12, at 7.
18.
Gostin, supra note 1, at xviii..
19.
U.S. Const.art. II, § 2.
20.
Id. at art. I, § 8.
21.
Thailand — Restrictions on Importation and Internal Taxes on Cigarettes, adopted November 7, 1990, GATT Doc. DS10/R, in Basic Instruments—Selected Documents 37S/200.
22.
D'AmatoA., “Is International Law Really ‘Law’?,”Northwestern University Law Review, 79 (1984): 1293–314.
23.
DelbrückJ., “Globalization of Law, Politics, and Markets — Implications for Domestic Law — A European Perspective,”Indiana Journal of Global Legal Studies, 1 (1993): 9–36.
24.
LeeK.DodgsonR., “Globalization and Cholera: Implications for Global Governance,”Global Governance, 6 (2000): 213–36.
25.
PrakashA.HartJ.A., eds., Globalization and Governance (London: Routledge, 1999);.
26.
ReinickeW.H., Global Public Policy: Governing without Government? (Washington, D.C.: Brookings Institute, 1998);.
27.
HeldD., Democracy and the Global Order: From the Modern State to Cosmopolitan Governance (Stanford: Stanford University Press, 1995).
FidlerD.P.PerezT.D.CetronM., “International Considerations,” in GoodmanR.A., eds., Law in Public Health Practice (Oxford: Oxford University Press, in press).
31.
World Health Organization, World Health Report 1996: Fighting Disease, Fostering Development (Geneva: WHO, 1996);
32.
U.S. Centers for Disease Control and Prevention, Addressing Emerging Infectious Disease Threats: A Prevention Strategy for the United States (Washington, D.C.: Department of Health and Human Services, 1994);
33.
Institute of Medicine, Emerging Infections: Microbial Threats to Health in the United States (Washington, D.C.: National Academy Press, 1992).
34.
Public Citizen, NAFTA's Broken Promises: Fast Track to Unsafe Food (Washington, D.C.: Public Citizen, 1997).
35.
DunneT., “Liberalism,” in BaylisJ.SmithS., eds., The Globalization of World Politics (Oxford: Oxford University Press, 1997): 147–63.
36.
Treaty Establishing the European Economic Community, March 25, 1957, in European Union: Selected Instruments Taken from the Treaties, vol. 1 (1995): 91–118.
37.
Treaty on European Union, in European Union: Selected Instruments Taken from the Treaties, vol. 1 (1995): 11–89.
38.
8 U.S.C.A. § 1182(a)(1)(A) (1999).
39.
Agreement on the Application of Sanitary and Phytosanitary Measures, December 15, 1993, in JacksonJ.H.DaveyW.J.SykesA.O.Jr., eds., 1995 Documents Supplement to Legal Problems of International Economic Relations (Minneapolis: West Publishing, 1995): 121–33, at Article 4 [hereinafter SPS Agreement].
40.
North American Free Trade Agreement, December 8, 1992, in International Legal Materials, 32 (1993): 289–456, at Article 714.
MillerJ.M., “Malaria, Intestinal Parasites, and Schistosomiasis Among Barawan Somali Refugees Resettling to the United States: A Strategy to Reduce Morbidity and Mortality and Decrease the Risk of Imported Infections,”American Journal of Tropical Medicine and Hygiene, 62 (2000): 115–21.
48.
Id.
49.
21 U.S.C.A. § 381(e)(1) (1999).
50.
Id.
51.
21 U.S.C.A. § 382(f)(4)(B) (1999).
52.
12 U.S.C.A. § 635i-5(a)(2) (2001);
53.
22 U.S.C.A. § 2191(n) (1990).
54.
15. U.S.C.A. § 1340 (1998).
55.
TaylorA.L., “An International Regulatory Strategy for Global Tobacco Control,”Yale Journal of International Law, 21 (1996): 257–304.
56.
World Health Organization Tobacco Free Initiative, Health Impact — Burden of Disease, at <http://tobacco.who.int/page.cfm?sid=47> (last visited April 18, 2002).
57.
Id.
58.
Intergovernmental Negotiating Body on the WHO Framework Convention on Tobacco Control, Chair's Text of a Framework Convention on Tobacco Control, 2nd Session, January 9, 2001, WHO Doc. A/FCTC/INB2/2, at Article E(3), available at <http://tobacco.who.int/repository/tpc40/en-text.pdf>.
59.
U.S. Const. art. VI.
60.
YachBettcher, “The Globalization of Public Health, I: Threats and Opportunities,”supra note 6, at 735–37;.
61.
Fidler, supra note 6, at 11–51.
62.
Delbrück, supra note 14, at 11.
63.
GoodmanN.M., International Health Organizations and Their Work, 2d ed. (London: Churchill Livingstone, 1972);.
64.
Howard-JonesN., The Scientific Background of the International Sanitary Conferences 1851–1938 (Geneva: World Health Organization, 1975);.
65.
FidlerD.P., “The Globalization of Public Health: The First 100 Years of International Health Diplomacy,”Bulletin of the World Health Organization, 79 (2001): 842–49.
66.
Gostin, supra note 1, at 4.
67.
FidlerD.P., International Law and Public Health (Ardsley, New York: Transnational Publishers, 2000);.
68.
FlussS.S., “International Public Health Law: An Overview,” in DetelsR., eds., The Oxford Textbook of Public Health, 3rd ed. (Oxford: Oxford University Press, 1997): 371–90.
69.
International Health Regulations, July 25, 1969, in WHO, International Health Regulations, 3rd ed. (Geneva: WHO, 1983).
70.
Convention on the Transboundary Effects of Industrial Accidents, March 17, 1992, in International Legal Materials, 31 (1992): 1330–62;
71.
Convention on Early Notification of a Nuclear Accident, September 26, 1986, in United Nations Treaty Series, vol. 1439: 275–90.
72.
Constitution of the World Health Organization, July 22, 1946, in WHO, Basic Documents, 40th ed. (Geneva: WHO, 1994): 1–18, at Article 2.
73.
Fidler, supra note 47, at 219–75.
74.
Id. at 427–51.
75.
Id. at 277–331.
76.
FidlerD.P., “Challenges to Humanity's Health: The Contributions of International Environmental Law to National and Global Public Health,”Environmental Law Reporter, 31 (2001): 10048–78.
77.
Gostin, supra note 1, at 4.
78.
KaulI.GrunbergI.SternM. A., “Defining Global Public Goods,” in KaulI.GrunbergI.SternM.A., eds., Global Public Goods (Oxford: Oxford University Press, 1999): 2–19.
79.
FidlerD.P., International Law and Infectious Diseases (Oxford: Clarendon Press, 1999): 233–42.
80.
Constitution of the World Health Organization, supra note 50, at 1 (Preamble).
81.
Universal Declaration of Human Rights, December 10, 1948, in BrownlieI., ed., Basic Documents in Human Rights, 3rd ed. (Oxford: Clarendon Press, 1992): 21–27, at Article 25.
82.
International Covenant on Economic, Social, and Cultural Rights, December 16, 1966, in BrownlieI., ed., Basic Documents in Human Rights3rd ed., (Oxford: Clarendon Press, 1992): 114–24, at Article 12.
83.
“Righting Wrongs,”The Economist, August 18, 2001, at 18–20.
84.
AttaranA., “Human Rights and Biomedical Research Funding for the Developing World: Covering State Obligations under the Right to Health,”Health and Human Rights, 4 (1999): 27–58.
85.
Fidler, supra note 54, at 10065–69.
86.
Gostin, supra note 1, at 4.
87.
Id.
88.
Fidler, supra note 57, at 172–79.
89.
International Covenant on Economic, Social, and Cultural Rights, supra note 60, at 115, Article 2.2.
90.
SPS Agreement, supra note 25, at Articles 2.3 and 5.1.
91.
Id. at Articles 2.3 and 5.6.
92.
General Agreement on Tariffs and Trade, April 15, 1994, in JacksonJ.H.DaveyW.J.SykesA.O.Jr., eds., 1995 Documents Supplement to Legal Problems of International Economic Relations (Minneapolis: West Publishing, 1995): 15–78.
93.
Agreement on Technical Barriers to Trade, April 15, 1994, in JacksonJ.H.DaveyW.J.SykesA.O.Jr., eds., 1995 Documents Supplement to Legal Problems of International Economic Relations (Minneapolis: West Publishing, 1995): 149–69.
94.
Agreement on Trade-Related Aspects of Intellectual Property Rights, April 15, 1994, in JacksonJ.H.DaveyW.J.SykesA.O.Jr., eds., 1995 Documents Supplement to Legal Problems of International Economic Relations (Minneapolis: West Publishing, 1995): 335–65.
95.
PecoulB., “Access to Essential Drugs in Poor Countries: A Lost Battle?,”JAMA, 281 (1999): 361–67.
96.
Agreement on Trade-Related Aspects of Intellectual Property Rights, supra note 72, at Articles 6 (parallel importing) and 31 (compulsory licensing).
97.
LeeDodgson, supra note 15.
98.
CharnovitzS., “Two Centuries of Participation: NGOs and International Governance,”Michigan Journal of International Law, 18 (1997): 183–286;.
99.
WillettsP., “Transnational Actors and International Organizations in Global Politics,” in BaylisJ.SmithS., eds., The Globalization of World Politics (Oxford: Oxford University Press, 1997): 287–310.
100.
World Medical Association, Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Subjects, rev. ed. (Edinburgh: 52nd World Medical Association General Assembly, October 2000), available at <http://www.wma.net/e/policy/17-c_e.html>.
101.
Council for International Organizations of Medical Sciences (CIOMS), International Ethical Guidelines for Biomedical Research Involving Human Subjects, rev. ed. (Geneva: CIOMS, 1993), available at <http://www.cioms.ch/frame_guidelines_january_2002.htm>.
102.
LurieP.WolfeS., “Unethical Trials of Interventions to Reduce Perinatal Transmission of the Human Immunodeficiency Virus in Developing Countries,”N. Engl. J. Med., 337 (1997): 853–56;.
103.
VarmusH.SatcherD., “Ethical Complexities of Conducting Research in Developing Countries,”N. Engl. J. Med., 337 (1997): 1003–05.
104.
KapsteinE., “The Corporate Ethics Crusade,”Foreign Affairs, 80, no. 5 (2001): 105–19, at 107.
WiddusR., “Public-Private Partnerships for Health: Their Main Targets, Their Diversity, and Future Directions,”Bulletin of the World Health Organization, 79 (2001): 713–20;.
110.
BuseK.WaltG., “Global Public-Private Partnerships: Part I — A New Development in Health?,”Bulletin of the World Health Organization, 78 (2000): 549–61;.
111.
BuseK.WaltG., “Global Public-Private Partnerships: Part II — What Are the Health Issues for Global Governance?,”Bulletin of the World Health Organization, 78 (2000): 699–709.
112.
GuptaR., “Responding to Market Failures in Tuberculosis Control,”Science, 293 (2001): 1049–51.